Santarus reps pushing Naprelan

Santarus said its sales reps will commence promotional activities in the third quarter for Victory Pharma's Naprelan brand products under a recent co-promotion agreement.

Naprelan tablets are a once daily control-release formulation of the non-steroidal anti-
inflammatory drug (NSAID) naproxen sodium, indicated for pain relief caused by a number of conditions including arthritis.

Santarus said it plans to promote Naprelan to targeted primary care physicians. Reps will also continue to promote the company's Rx heartburn treatment Zegerid to gastroenterologists and primary care doctors alongside reps from inVentiv and Otsuka America.  

You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical


Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.